-
Rite Aid’s Q3 shows growth in Elixir, headwinds in pharmacy margin
For the third quarter, Rite Aid reported a net loss of $67.1 million, or $1.23 loss per share, adjusted net loss of $7.9 million, or 14 cents loss per share. -
Retailers providing updated COVID-19 bivalent vaccine to children
Following guidance from the CDC and FDA, Walgreens, Rite Aid and Bartell Drugs are beginning to offer the updated COVID-19 bivalent vaccine to children aged 3 and older.